BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8830012)

  • 1. The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from Citrobacter freundii.
    Stapleton P; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Sep; 36(3):483-96. PubMed ID: 8830012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of FCE 22101 with class I beta-lactamases.
    Yang Y; Livermore DM
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():85-94. PubMed ID: 2786519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA sequence differences of ampD mutants of Citrobacter freundii.
    Stapleton P; Shannon K; Phillips I
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2494-8. PubMed ID: 8585732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.
    Babini GS; Yuan M; Livermore DM
    Antimicrob Agents Chemother; 1998 May; 42(5):1168-75. PubMed ID: 9593145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
    Yang YJ; Livermore DM
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.
    Livermore DM
    Eur J Clin Microbiol; 1987 Aug; 6(4):439-45. PubMed ID: 3311738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.
    Sanders CC; Sanders WE
    J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.
    Livermore DM; Yang YJ
    J Infect Dis; 1987 Apr; 155(4):775-82. PubMed ID: 3102630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of beta-lactamase by cefoxitin in anaerobic intestinal microflora.
    Stark C; Edlund C; Hedberg M; Nord CE
    Eur J Clin Microbiol Infect Dis; 1995 Jan; 14(1):18-24. PubMed ID: 7729448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.
    Curtis NA; Eisenstadt RL; Rudd C; White AJ
    J Antimicrob Chemother; 1986 Jan; 17(1):51-61. PubMed ID: 3485092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin, salicylate, and 2,4-dinitrophenol decrease production of AmpC-type beta-lactamase in two Citrobacter freundii clinical isolates.
    Tavío MM; Perilli M; Vila J; Becerro P; Ruiz J; Amicosante G; De Anta MT
    Microb Drug Resist; 2005; 11(3):225-31. PubMed ID: 16201924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and laboratory significance of inducible beta-lactamases].
    Bedenić B; Zagar Z
    Lijec Vjesn; 1995; 117(9-10):249-53. PubMed ID: 8643019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad spectrum beta-lactamases of Citrobacter diversus.
    Oliva B; Segatore B; Amicosante G; Franceschini N; Oratore A; Bennett PM
    J Antimicrob Chemother; 1990 Mar; 25(3):335-41. PubMed ID: 2338412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
    Binfiglio G; Stefani S; Nicoletti G
    Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii.
    Cullmann W; Dick W
    Eur J Clin Microbiol; 1985 Feb; 4(1):34-40. PubMed ID: 3872794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of imipenem on strains of Enterobacteriaceae expressing Richmond & Sykes class I beta-lactamases.
    Ashby J; Kirkpatrick B; Piddock LJ; Wise R
    J Antimicrob Chemother; 1987 Jul; 20(1):15-22. PubMed ID: 3497914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of permeability in the activities of beta-lactams against gram-negative bacteria which produce a group 3 beta-lactamase.
    Matsumura N; Minami S; Watanabe Y; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2084-6. PubMed ID: 10428944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the ampD gene causes semiconstitutive overproduction of the inducible Citrobacter freundii beta-lactamase.
    Lindberg F; Lindquist S; Normark S
    J Bacteriol; 1987 May; 169(5):1923-8. PubMed ID: 3032901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC; Shlaes DM
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.